Patolop Dosage/Direction for Use

The dose is one drop of Olopatadine Hydrochloride in the conjunctival sac of the affected eye or eyes twice daily (8 hourly). Treatment may be maintained for up to four months if considered necessary.
Method of administration: Inspect visually for particulate matter and discoloration prior to administration.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use.
In the case of concomitant therapy with other topical ocular medicines, an interval of five to ten minutes should be allowed between successive applications.
Additional data about special populations: Kidney/liver failure: Olopatadine in the form of eye drops (Olopatadine Hydrochloride) has not been studied in patients with kidney and liver failure. However, no dosage adjustment is expected to be necessary in patients with kidney and liver failure.
Pediatric population: Olopatadine Hydrochloride may be used in pediatric patients (three years of age and older) at the same dose as in adults.
Geriatric population: No dosage adjustment in elderly patients is necessary.